[HTML][HTML] Korean clinical practice guidelines on biologics for moderate to severe Crohn's disease

SJ Koh, SN Hong, SK Park, BD Ye, KO Kim… - Intestinal …, 2023 - ncbi.nlm.nih.gov
Crohn's disease (CD) is a relapsing and progressive condition characterized by diarrhea,
abdominal pain, weight loss, and hematochezia that results in serious complications such as …

Biomarkers for the prediction and diagnosis of fibrostenosing Crohn's disease: a systematic review

CA Steiner, JA Berinstein, J Louissaint… - Clinical …, 2022 - Elsevier
Background and Aims Intestinal strictures are a common complication of Crohn's disease
(CD). Biomarkers of intestinal strictures would assist in their prediction, diagnosis, and …

The American Society of Colon and Rectal Surgeons clinical practice guidelines for the surgical management of Crohn's disease

AL Lightner, JD Vogel, JC Carmichael… - Diseases of the Colon …, 2020 - journals.lww.com
The American Society of Colon and Rectal Surgeons (ASCRS) is dedicated to ensuring high-
quality patient care by advancing the science, prevention, and management of disorders …

Combined biologic and immunomodulatory therapy is superior to monotherapy for decreasing the risk of inflammatory bowel disease-related complications

LE Targownik, EI Benchimol… - Journal of Crohn's …, 2020 - academic.oup.com
Abstract Background and Aims The combination of infliximab and azathioprine is more
efficacious than either therapy alone for Crohn's disease [CD] and ulcerative colitis [UC] …

High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists

A Guo, C Ross, N Chande, J Gregor, T Ponich… - Scientific Reports, 2022 - nature.com
The interleukin-6 family cytokine, oncostatin-M (OSM) has been associated with response to
tumor necrosis factor-α antagonists (anti-TNFs) in small cohorts of patients with inflammatory …

Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial

C Zhou, M Li, Y Zhang, M Ni, Y Wang, D Xu… - Stem cell research & …, 2020 - Springer
Background Crohn's fistula-in-ano is a refractory disease in colorectal and anal surgery.
Although autologous adipose-derived stem cell (ADSC) has been used in the treatment of …

Significant racial and ethnic disparities exist in health care utilization in inflammatory bowel disease: a systematic review and meta-analysis

P Tandon, T Chhibba, N Natt… - Inflammatory Bowel …, 2024 - academic.oup.com
Background The incidence of inflammatory bowel disease (IBD) is rising worldwide, though
the differences in health care utilization among different races and ethnicities remains …

Nutritional therapies and their influence on the intestinal microbiome in pediatric inflammatory bowel disease

L Hart, CM Verburgt, E Wine, M Zachos, A Poppen… - Nutrients, 2021 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic, autoimmune disorder of the gastrointestinal
tract with numerous genetic and environmental risk factors. Patients with Crohn's disease …

Efficacy and safety of methotrexate in the management of inflammatory bowel disease: a systematic review and meta-analysis of randomized, controlled trials

OH Nielsen, C Steenholdt, CB Juhl, G Rogler - EClinicalMedicine, 2020 - thelancet.com
Background The therapeutic role of methotrexate (MTX) for management of inflammatory
bowel disease (IBD) remains unclear. Methods We systematically reviewed randomized …

Exploring the outcomes of research engagement using the observation method in an online setting

DA Marshall, N Suryaprakash, DC Lavallee… - BMJ open, 2023 - bmjopen.bmj.com
Objective The objective of this study was to explore the outcomes of research engagement
(patient engagement, PE) in the context of qualitative research. Design We observed …